NDC 0955-1020 – Docetaxel
Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC0955-1020
Product details
- Brand name
- Docetaxel
- Generic name
- Docetaxel
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- NDA AUTHORIZED GENERIC · NDA020449
- Marketed since
- October 21, 2010
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Docetaxel 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0955-1020-01 | 1 VIAL, GLASS in 1 CARTON (0955-1020-01) / 1 mL in 1 VIAL, GLASS | Oct 21, 2010 |
Recalls mentioning this NDC
- D-0804-2018 May 9, 2018 · Class II
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
Other Docetaxel products
- 16729-267 Docetaxel Anhydrous 20 mg/mL · Injection, Solution, Concentrate · Accord Healthcare Inc.
- 45963-734 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 45963-765 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 0143-9204 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Hikma Pharmaceuticals USA Inc.
- 0143-9205 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Hikma Pharmaceuticals USA Inc.
- 57884-3041 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 57884-3042 Docetaxel 80 mg/4mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 57884-3043 Docetaxel 160 mg/8mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 71288-133 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-152 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 67457-781 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Mylan Institutional LLC
- 0955-1021 Docetaxel 80 mg/4mL · Injection, Solution, Concentrate · Sanofi-Aventis U.S. LLC